Neumora Therapeutics
novel approach for the treatment of schizophrenia | Neumora Therapeutics
Company
Deck Type
IPO
Sector
Industry
Deck date
September 2023
Slide
21 of 32
Related slides by other companies
Alkermes
Investor Conference
January 2022
oral treatment option for adults with schizophrenia or bipolar i disorder available | Alkermes
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights